The cosmetic market in the United States is highly competitive, and brands must understand FDA requirements to stay compliant and protect consumers. This article explains the main FDA rules for cosmetics, what has changed under MoCRA, and what practical steps brands should follow before launching products.
Fda Requirements For Cosmetics
FDA requirements for cosmetics are built primarily on the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA). Unlike drugs, most cosmetics do not need premarket FDA approval, but they must not be adulterated or misbranded and must meet labeling and safety obligations. Companies and individuals who market cosmetics have the legal responsibility to ensure their products are safe and properly labeled before they reach consumers.
These requirements cover several areas, including ingredient safety, facility practices, product labeling, and how companies handle adverse events. Failure to meet these standards can lead to warning letters, product seizures, recalls, or other enforcement actions that damage both revenue and reputation. With the introduction of the Modernization of Cosmetics Regulation Act (MoCRA), the FDA now has stronger tools to oversee cosmetic manufacturing, registration, and safety substantiation.
Understanding Fda Requirements For Cosmetics?
To understand fda requirements for cosmetics, it helps to start with what the FDA does and does not “approve.” The agency clearly states that cosmetics and their ingredients, except for most color additives, do not require FDA approval before going to market. However, the FD&C Act still prohibits the marketing of cosmetics that are unsafe, contaminated, or improperly labeled, so brands must prove safety themselves before launch.
Under MoCRA, manufacturers and packers are now required to register their facilities with the FDA and list the cosmetic products they manufacture or distribute. This registration and product listing framework gives the FDA better visibility into who is making what, which helps the agency monitor safety issues and conduct risk‑based inspections. Brands also need to implement safety substantiation, meaning they must maintain data showing that each cosmetic is safe for its intended use, such as toxicological assessments, stability tests, or other scientific evidence.
Ingredient Safety And Prohibited Substances
One of the most practical parts of FDA requirements for cosmetics involves what goes into a product and how that is evaluated for safety. The FDA expects manufacturers to ensure their ingredients and finished formulas are safe under labeled or customary conditions of use, which usually involves reviewing toxicological data, published literature, and, in some cases, clinical testing. While the FDA does not maintain a comprehensive positive list of cosmetic ingredients like some other regulators, it does restrict or prohibit certain substances and continues to monitor safety concerns as new data emerges.
Color additives are treated differently from other cosmetic ingredients. With limited exceptions, color additives used in cosmetics must be specifically approved by the FDA and, for some, batches must be certified before use. Using an unapproved color additive, or using an approved additive outside its permitted conditions, automatically makes a cosmetic adulterated under the FD&C Act. Responsible brands therefore cross‑check their color additives against FDA listings and maintain documentation that shows they comply with the allowed categories, uses, and concentrations.
Labeling And Packaging Obligations
Labeling is another core component of FDA requirements for cosmetics, and it is where many compliance issues emerge. Under the FPLA and related regulations, most retail cosmetics must carry an ingredient declaration, listing ingredients in descending order of predominance. The principal display panel also needs to show the product identity and net quantity of contents, while the information panel must include name and place of business of the manufacturer, packer, or distributor. If a product lacks required information or presents it in a misleading way, it may be considered misbranded.
Certain terms on labels can be particularly sensitive. If a cosmetic makes claims that imply it can treat, cure, or prevent disease, or affect the structure or function of the body, it may be regulated as a drug, an area where full FDA approval and monograph compliance may apply. Brands therefore need to ensure their marketing language stays within cosmetic territory—focusing on appearance, cleansing, beautifying, or promoting attractiveness—unless they intentionally choose an OTC or drug pathway with stricter requirements.
Mocra And Modern Cosmetic Regulation
The Modernization of Cosmetics Regulation Act of 2022 is the biggest update to U.S. cosmetic law in decades, reshaping what compliance looks like in practice. Before MoCRA, FDA oversight of cosmetics relied heavily on general misbranding and adulteration provisions, voluntary programs, and post‑market actions. Now, MoCRA introduces mandatory facility registration, product listing, safety substantiation, adverse event reporting, expanded recordkeeping, and increased inspection and recall authority.
Mandatory facility registration requires cosmetic manufacturers and certain packers to register with the FDA and renew periodically. This registration includes basic information about where products are made or processed, which helps the FDA plan inspections and respond quickly during safety investigations. Product listing, meanwhile, requires companies to submit specific information about each marketed cosmetic, such as product category, ingredients, and responsible person details. Together, these steps move the industry from a largely voluntary framework toward a more structured regulatory system similar to that for other FDA‑regulated products.
Practical checklist to meet FDA requirements for cosmetics
Turning legal requirements into daily operations can be challenging, so many companies use a structured checklist to manage compliance. A typical practical approach includes reviewing product composition, verifying labeling, registering facilities, and organizing documentation and audits. Starting with ingredients, brands should confirm that none are prohibited or restricted beyond allowed concentrations and that any color additives meet FDA approval and use conditions.
Label and packaging compliance should be reviewed before printing or going live online. This means confirming ingredient declarations, net contents, identity statements, required warnings, and business information. Where products make borderline claims, teams should coordinate between regulatory, marketing, and legal departments to ensure they do not unintentionally cross into drug territory. At the facility level, manufacturers should register with the FDA, implement good manufacturing practices, and be prepared for inspections by keeping records such as batch documentation, cleaning logs, and quality control test reports.
Conclusion
FDA requirements for cosmetics are evolving, but the core expectations remain clear: products must be safe, properly labeled, and manufactured under reliable quality systems. With MoCRA, the FDA now has enhanced tools to oversee facility registration, product listing, safety substantiation, labeling, and adverse event reporting, which makes structured compliance more important than ever for cosmetic brands.
Resource URL:
https://cosmeticsregulatory.com/blog/how-to-get-fda-approval-for-cosmetics/
